Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.50 |
| ▸ | RPA1 | P27694 | 1/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.48 |
| ▸ | MARS1 | P56192 | 4/20 | 0.46 |
| ▸ | CNR1 | P21554 | 10/20 | 0.44 |
| ▸ | CNR2 | P34972 | 10/20 | 0.44 |
| ▸ | GABRA2 | P47869 | 1/20 | 0.42 |
| ▸ | GABRB2 | P47870 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4192493 | 0.85 | CNR2 (0.57) | RPA1CNR1CNR2 | |
| SCHEMBL6515355 | 0.83 | ALDH1A1 (0.46) | LMNAALDH1A1 | |
| SCHEMBL5769070 | 0.82 | KDM4E (0.58) | ALDH1A1CNR1CNR2GABRA2GABRB2 | |
| SCHEMBL7047587 | 0.82 | LMNA (0.46) | LMNARPA1ALDH1A1CNR1CNR2 | |
| SCHEMBL2561030 | 0.81 | LMNA (0.43) | LMNARPA1ALDH1A1MARS1CNR1 | |
| SCHEMBL29958261 | 0.81 | LMNA (0.43) | LMNARPA1ALDH1A1MARS1CNR1 | |
| SCHEMBL15333245 | 0.79 | LMNA (0.53) | LMNARPA1CNR1CNR2 | |
| SCHEMBL6886607 | 0.77 | KDM4E (0.53) | LMNARPA1ALDH1A1MARS1CNR1 | |
| Hydrochloric Acid SCHEMBL6770419 | 0.76 | KDM4E (0.52) | LMNARPA1ALDH1A1MARS1CNR1 | |
| SCHEMBL2679077 | 0.76 | NPSR1 (0.39) | ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1622876-A1 | CANNABINOID RECEPTOR LIGANDS AND USES THEREOF | Pfizer Products Inc. (US) | 2006-02-08 | — | — | EP | disclosed |
| US-20040235926-A1 | Cannabinoid receptor ligands and uses thereof | PFIZER INC. | 2004-11-25 | — | — | US | disclosed |
| WO-2004099157-A1 | CANNABINOID RECEPTOR LIGANDS AND USES THEREOF | PFIZER PRODUCTS INC. (US) | 2004-11-18 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040235926-A1 | Cannabinoid receptor ligands and uses thereof | CNR1, CNR2, GPR18 | LMNA 3194/4885RPA1 4560/4885ALDH1A1 1547/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.